Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | KT-413 |
Trade Name | |
Synonyms | KT413|KT 413 |
Drug Descriptions |
KT-413 degrades IRAK4, IKZF1 (Ikaros), and IKZF3 (Aiolos), potentially leading to tumor cell killing and inhibition of tumor growth (Cancer Res 2021;81(13_Suppl):Abstract nr LB118). |
DrugClasses | IRAK4 Inhibitor 7 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
KT-413 | KT-413 | 0 | 1 |